5.66
price up icon4.04%   0.22
after-market Handel nachbörslich: 5.66
loading

Finanzdaten der Annexon Inc-Aktie (ANNX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
10.23%
57.02
51.73 57.41 39.44 33.58
Operating Income/Loss
10.23%
-57.02
-51.73 -57.41 -39.44 -33.58
Income/Loss From Continuing Operations Before Tax
11.73%
-54.92
-49.16 -54.36 -34.82 -29.61
Income/Loss From Continuing Operations After Tax
11.73%
-54.92
-49.16 -54.36 -34.82 -29.61
Net Income/Loss
11.73%
-54.92
-49.16 -54.36 -34.82 -29.61
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.54%
149.12
148.32 148.11 139.93 130.13
Diluted Average Shares
0.54%
149.12
148.32 148.11 139.93 130.13
Basic Earnings Per Share
8.82%
-0.37
-0.34 -0.37 -0.25 -0.23
Diluted Earnings Per Share
8.82%
-0.37
-0.34 -0.37 -0.25 -0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):